Competition & Peer Data API & CSV Delivery

American Cannabis Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of American Cannabis Inc (AMMJ) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2024
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-49.35 %
Q2 2024
Net Margin
-147.30 %
Q2 2024

Key Findings: American Cannabis Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 2M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+8.1% annualized vs trailing 12 months).
  • Peer revenue share: American Cannabis Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

AMMJ Sales vs. its Competitors, Q2 2024

American Cannabis Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/AMMJ/competitors
https://api.csimarket.com/api/v1/companies/AMMJ/relationships
https://api.csimarket.com/api/v1/companies/AMMJ/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Legal Cannabis industry grew revenue 35.0% year over year, combined, vs -49.4% for American Cannabis Inc. American Cannabis Inc's share of combined industry revenue moved from 0.04% to 0.01%, a loss of 0.02 percentage points.

American Cannabis Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
American Cannabis Company Inc No No No Yes
High-Confidence Competitors (1) - - - 100%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2024

100%market share
  • American Cannabis Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of American Cannabis Inc and its 0 tracked competitors.

See American Cannabis Inc's full market share breakdown »

AMMJ Stock Performance relative to its Competitors

AMMJ Competitors (weighted) Percent change over the selected range

AMMJ Stock Performance relative to High-Confidence Competitors

AMMJ High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

American Cannabis Inc's Comment on Competition and Industry Peers

The company operates in the regulated cannabis industry, competing with professional services firms, cannabis dispensaries, and suppliers of equipment and supplies used in cannabis cultivation, processing, or retail sale. Its markets include various U.S. states, territories, Indian Country, and Canada where cannabis is legalized and regulated. The competitive environment is expected to change as the industry matures and new states and regions enter the market due to regulatory and legislative developments. The company maintains an established presence and offers a range of services and products within this evolving landscape.

American Cannabis Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Medbox, Inc. Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for American Cannabis Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.